Location

Please check the individual session for location or broadcast availability.  

Frequency

Weekly

Series Director

Babith Mankidy, MD

Target Audience

Needs Statement

To address practice gaps in the application of evidence-based, multidisciplinary care for patients with lung and esophageal cancers, clinicians require structured opportunities to engage in multidisciplinary discussions that reinforce guideline-concordant care, improve diagnostic accuracy, and support shared decision-making. This tumor board serves as a critical educational platform where specialists can collaboratively review complex cases, interpret evolving evidence, and align on best practices. There is a need for ongoing education in the application of guidelines, interpretation of molecular and imaging data, and integration of emerging therapies. The aim of the tumor board is to bring together all specialties involved in the treatment of thoracic malignancies to ensure coordinated, evidence-based decision-making.

Educational Methods

Educational methods will include case presentations and panel discussion.

Objectives

At the conclusion of the sessions, the participants should be able to:

• Explain the subtypes and staging of thoracic malignancies. 
• Identify appropriate diagnostic pathways, including advanced imaging techniques, pathology, and molecular testing, to support accurate diagnosis. 
• Formulate evidence-based, multimodal treatment plans in accordance with National Comprehensive Cancer Network (NCCN) guidelines and current best practices.
• Evaluate the impact of multidisciplinary collaboration on treatment planning, patient outcomes, and adherence to clinical guidelines

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator